Who is sponsoring NCT05919316?

NCT05919316 is sponsored by National University of Malaysia.

What condition does NCT05919316 study?

NCT05919316 studies Allergic Rhinitis.

What drugs are being tested in NCT05919316?

Interventions: Rhinophototherapy, Nasonex Nasal Spray.

What is the status of NCT05919316?

NCT05919316 is currently UNKNOWN.

Last reviewed 2024-03-21 · How we verify

The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa

NCT05919316 NA UNKNOWN

The aim of this study to compare the efficacy of Rhinophototherapy to Intranasal Corticosteroids on the the nasal mucosa of allergic rhinitis patients. The main question to answer is: Does intranasal phototherapy reduce inflammation in the tissue biopsy of the inferior turbinate mucosa compared to intranasal steroids? The hypothesis for this study is Intranasal phototherapy will reduce mucosal inflammation without mucosal damage and is comparable to intranasal steroids in allergic rhinitis patients

Details

Lead sponsor	National University of Malaysia
Phase	NA
Status	UNKNOWN
Enrolment	40
Start date	Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Allergic Rhinitis

Interventions

Rhinophototherapy
Nasonex Nasal Spray

Countries

Malaysia